Study to Evaluate the Efficacy of Botulinum Toxin Serotype A Injections for Cervicobrachial Myofascial Syndrome
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Several studies have previously examined the use of botulinum toxin serotype A for myofascial
pain of the neck and shoulders (cervicobrachial syndrome). These studies have suffered from:
1. inclusion of confounding conditions in the proband group, and
2. inability to identify predictors of response.
This study attempts to define the characteristics of responders to botulinum serotype A for
myofascial pain of the neck and shoulders (cervicobrachial syndrome).